Md Tabish Rehman Selected Research

SARS-CoV-2 3C-like proteinase

1/2021	Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19.
10/2020	Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy.
1/2020	Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy.
1/2020	Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Md Tabish Rehman Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 01/2015
8	COVID-19 10/2022 - 01/2020
7	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2022 - 01/2019
5	Alzheimer Disease (Alzheimer's Disease) 09/2021 - 01/2020
2	Infections 10/2021 - 01/2021
2	Genomic Instability 01/2020 - 01/2019
2	Neoplasm Metastasis (Metastasis) 02/2019 - 01/2019
2	Neuroblastoma 01/2019 - 12/2018
1	Obesity 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Dementia (Dementias) 12/2021
1	Chronic Disease (Chronic Diseases) 10/2021
1	Iron Overload 03/2021
1	Iron Deficiencies 03/2021
1	Bacterial Infections (Bacterial Infection) 03/2021
1	Cerebroretinal Microangiopathy with Calcifications and Cysts 01/2021
1	Bruton type agammaglobulinemia 12/2020
1	Diabetes Complications 09/2020
1	Leukemia 06/2020
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020
1	Rheumatoid Arthritis 06/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Breast Neoplasms (Breast Cancer) 05/2018

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 01/2022 - 01/2015
4	SARS-CoV-2 3C-like proteinaseIBA 01/2021 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 09/2020 - 05/2019
3	LigandsIBA 01/2021 - 01/2015
3	Phosphotransferases (Kinase)IBA 12/2020 - 02/2019
3	EnzymesIBA 09/2020 - 10/2019
3	sphingosine kinaseIBA 06/2020 - 10/2019
2	Antiviral Agents (Antivirals)IBA 10/2021 - 01/2021
2	Biological ProductsIBA 09/2021 - 01/2021
2	FlavonoidsIBA 01/2021 - 01/2021
2	Human Serum Albumin FDA LinkGeneric 05/2020 - 01/2015
2	tartaric acid (tartrate)FDA Link 01/2020 - 01/2019
2	Rivastigmine (Exelon)FDA LinkGeneric 01/2020 - 01/2019
1	SolutionsIBA 04/2022
1	soyasapogenol BIBA 04/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2022
1	Lapatinib (GW572016)FDA Link 10/2021
1	Sitagliptin Phosphate (Januvia)FDA Link 10/2021
1	Celecoxib (Celebrex)FDA Link 10/2021
1	Glipizide (Glucotrol)FDA LinkGeneric 10/2021
1	Amyloid (Amyloid Fibrils)IBA 05/2021
1	MetalsIBA 03/2021
1	IronIBA 03/2021
1	naringeninIBA 03/2021
1	PolyphenolsIBA 03/2021
1	Ferritins (Ferritin)IBA 03/2021
1	QuercetinIBA 03/2021
1	FluoroquinolonesIBA 03/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2021
1	Ciprofloxacin (Cipro)FDA LinkGeneric 03/2021
1	Pyruvic Acid (Pyruvate)IBA 02/2021
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 02/2021
1	Multifunctional EnzymesIBA 02/2021
1	umifenovirIBA 01/2021
1	favipiravirIBA 01/2021
1	remdesivirIBA 01/2021
1	AcetylcholinesteraseIBA 01/2021
1	Antimalarials (Antimalarial Agents)IBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	Glycogen Synthase (Synthase I)IBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	NucleotidesIBA 01/2021
1	Plant ExtractsIBA 01/2021
1	VitaminsIBA 01/2021
1	Ritonavir (Norvir)FDA Link 01/2021
1	Lopinavir FDA Link 01/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 12/2020
1	Aldehyde Reductase (Aldose Reductase)IBA 09/2020
1	DNA (Deoxyribonucleic Acid)IBA 05/2020
1	alpha-Linolenic Acid (Linolenic Acid)IBA 05/2020
1	calf thymus DNAIBA 05/2020
1	OligosaccharidesIBA 01/2020
1	Maraviroc FDA Link 01/2020
1	glecaprevirIBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	OligonucleotidesIBA 01/2020
1	Donepezil (Aricept)FDA LinkGeneric 01/2020
1	SphingolipidsIBA 10/2019
1	cinnamaldehyde (cinnamic aldehyde)FDA Link 06/2019
1	EugenolIBA 06/2019
1	AntioxidantsIBA 06/2019
1	HydrazonesIBA 02/2019
1	IsatinIBA 02/2019
1	TriazolesIBA 02/2019
1	Transferrin (beta 2 Transferrin)IBA 01/2019
1	HesperidinIBA 01/2019
1	SilverIBA 01/2019
1	Shelterin ComplexIBA 01/2019
1	Rutin (Rutoside)IBA 12/2018
1	Cisplatin (Platino)FDA LinkGeneric 05/2018
1	Blood Proteins (Serum Proteins)IBA 01/2015

Therapy/Procedure

9	Therapeutics 10/2022 - 06/2019
1	Unani Medicine 10/2022
1	Chemoprevention 01/2021